|
Volumn 16, Issue 2, 2001, Pages 184-191
|
Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease
|
Author keywords
Alzheimer's disease; Dementia; Neuropsychiatric symptoms; Parkinson's disease
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANTIPARKINSON AGENT;
ANXIOLYTIC AGENT;
BENZODIAZEPINE;
BROMOCRIPTINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
HYPNOTIC AGENT;
LEVODOPA;
NEUROLEPTIC AGENT;
SELEGILINE;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
AGED;
AGITATION;
ALZHEIMER DISEASE;
APATHY;
ARTICLE;
COGNITIVE DEFECT;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DELUSION;
DEMENTIA;
EUPHORIA;
FEMALE;
HALLUCINATION;
HUMAN;
INTERVIEW;
IRRITABILITY;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
MOTOR DYSFUNCTION;
NEUROPSYCHIATRY;
PARKINSON DISEASE;
POPULATION RESEARCH;
PREVALENCE;
PSYCHOMETRY;
AGED;
ALZHEIMER DISEASE;
ANTIDEPRESSIVE AGENTS;
ANTIPSYCHOTIC AGENTS;
CROSS-SECTIONAL STUDIES;
DEMENTIA;
FEMALE;
HUMANS;
MALE;
MENTAL DISORDERS;
NEUROPSYCHOLOGICAL TESTS;
NORWAY;
PARKINSON DISEASE;
SEVERITY OF ILLNESS INDEX;
STATISTICS, NONPARAMETRIC;
|
EID: 0035114397
PISSN: 08856230
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-1166(200102)16:2<184::AID-GPS304>3.0.CO;2-K Document Type: Article |
Times cited : (131)
|
References (43)
|